Dear Colleagues,

Pharmaceuticals and personal care products (PPCPs) have been considered emerging environmental contaminants for a decade since they are not completely eliminated by traditional water and wastewater treatment methods. This has become a topic of major concern as PPCPs are widely and increasingly used in human and veterinary medicine, resulting in their continued release to the environment through domestic and hospital sewage and agricultural farms. An increasing number of studies have confirmed the presence of various PPCPs in different environmental compartments (e.g., water, sediments, and soils) at concentrations capable of causing detrimental effects to humans, animals, and the ecosystem. The environmental risk posed by these contaminants is assessed in light of persistence criteria, potential for elimination in wastewater treatment plants, transfer and bioaccumulation in the food chain, and toxicity.

This Special Issue aims to focus on the compilation of the current state of the art and future perspectives in pharmaceutical and human care products toward an integrated One Health approach with regard to:

• Widespread occurrence of PPCPs in different environmental compartments;
• Treatment and removal efficiencies of PPCPs;
• Fate of PPCPs in aquatic and terrestrial ecosystems;
• Monitoring and detection methods of PPCPs;
• Toxicity, ecotoxicity, and phytotoxicity of PPCPs;
• Transfer of PPCPs in the food chain and associated threats to animal and human heath;
• Risk assessment in terms of environment and animal and human health;
• Laboratory, field, and modeling approaches to the above issues.

Dr. Noureddine Bouaïcha
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Xenobiotics is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• pharmaceutical drugs
• personal care products
• treatment and removal
• measurement and monitoring
• ecotoxicity
• food chain
• human and animal health
• risk assessment